Profile picture

Associate Professor Philip D Adamson

University of Otago Christchurch, Christchurch (New Zealand)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Dual antiplatelet therapy to inhibit myocardial injury in patients with high-risk coronary artery plaque: a randomized controlled trial
Presentation
Dual antiplatelet therapy to inhibit myocardial injury in patients with high-risk coronary artery plaque: a randomized controlled trial
Impact of international guidelines' differing approaches to the risk stratification of patients with suspected stable angina: Insights form PROMISE and SCOT-HEART
Presentation
Impact of international guidelines' differing approaches to the risk stratification of patients with suspected stable angina: Insights form PROMISE and SCOT-HEART
Prognostic value of convalescent high-sensitivity troponin I concentrations following acute coronary syndrome
Presentation
Prognostic value of convalescent high-sensitivity troponin I concentrations following acute coronary syndrome
Diagnostic and prognostic benefits of CTCA using the updated NICE guidance: An analysis of the Scottish computed tomography of the heart (SCOT-HEART) trial
Presentation
Diagnostic and prognostic benefits of CTCA using the updated NICE guidance: An analysis of the Scottish computed tomography of the heart (SCOT-HEART) trial

ESC 365 is supported by